Empery Asset Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
Empery Asset Management's MTRI Position: Q2 2022 in Review
Empery Asset Management sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q2 2022, closing a stake of 12 shares — an estimated $58K sold.
Empery Asset Management first reported a position in MTRI in Q1 2022 and held it in 1 quarter. The position peaked at $58K in Q1 2022. 6 funds tracked by Wall St. Rank hold MTRI as of Q2 2022.
- Empery Asset Management reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Empery Asset Management sold 12 Mentari Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $58K.
- Empery Asset Management first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
- Empery Asset Management's Mentari Therapeutics, Inc. Common Stock position peaked at $58K in Q1 2022.
- 6 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q2 2022.
Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.